New FTD CCHFV kit launched
Crimean Congo haemorrhagic fever virus (CCHFV) is a tick-borne virus of the Bunyaviridae family. The virus is endemic in Africa, the Balkans and the Middle East and Asia. The transmission occurs via bites from infected ticks or via human-to-human by close contact with blood, secretions or body fluids. After an incubation period of one to three days (five to six day after human-to-human infection) the onset of fever, myalgia, stiffness, headache, sore eyes and photophobia happens. It can also be combined with tachycardia, lymphadenopathy and a petechial rash. The mortality rate is about 30%.
- A one tube multiplex real-time PCR assay for detection of Crimean Congo haemorrhagic fever virus and internal control.
- A CE labelled, in vitro test for the qualitative detection of viral nucleic acid in whole blood samples as an aid to the evaluation of infections with Crimean Congo haemorrhagic fever virus.
- Contains all the reagents necessary including: Optimised primer and probe mixes, Positive control, Negative control, Internal control and Fast track mastermix – our one step enzyme plus buffer.
- For more information see our Product Manual.
We are compatible with ten of the most widely used plaatforms. For more information on our compatibility with your platform or extraction method, see our compatibility list.
This test is for use with extracted nucleic acid from whole blood of human origin.
To order please contact email@example.com and let us know which kit size you would like. The options are:
- FTD-69-32 Test for 32 reactions.
- FTD-69-64 Test for 64 reactions.
Note: Reagents in the kits are sufficient for 32 or 64 reactions. These kit sizes allow maximal flexibility from 1 to 28 patients in FTD-69-32 and 1 to 60 patients in FTD-69-64.